The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Dibiase Mary since 2022.
This trader's CIK number is 1880179.
At the time of last reporting, Dibiase Mary was the Chief Operating Officer of X4 Pharmaceuticals, Inc. (stock ticker symbol XFOR).
Also see all insider trading activities at X4 Pharmaceuticals, Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | XFOR | 0 | $0 | 22,258 | $10,105 | 0 | $0 |
| 2024 | XFOR | 0 | $0 | 89,429 | $57,351 | 0 | $0 |
| 2023 | XFOR | 0 | $0 | 93,270 | $75,093 | 0 | $0 |
| 2022 | XFOR | 0 | $0 | 5,003 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-01-24 | XFOR | Sale | 22,258 | .45 | 10,105 |
| 2024-10-07 | XFOR | Sale | 67,695 | .57 | 38,315 |
| 2024-09-09 | XFOR | Sale | 2,642 | .66 | 1,738 |
| 2024-03-11 | XFOR | Sale | 15,409 | .88 | 13,590 |
| 2024-02-12 | XFOR | Sale | 3,683 | 1.01 | 3,708 |
| 2023-11-01 | XFOR | Sale | 67,695 | .73 | 49,417 |
| 2023-06-30 | XFOR | Sale | 464 | 1.89 | 876 |
| 2023-06-23 | XFOR | Sale | 857 | 1.93 | 1,654 |
| 2023-06-15 | XFOR | Sale | 857 | 2.23 | 1,911 |
| 2023-06-15 | XFOR | Sale | 857 | 2.23 | 1,911 |
| 2023-03-10 | XFOR | Sale | 18,192 | .84 | 15,281 |
| 2023-02-13 | XFOR | Sale | 4,348 | .93 | 4,043 |
| 2022-08-17 | XFOR | Sale | 1,713 | .00 | 0 |
| 2022-06-30 | XFOR | Sale | 1,578 | .00 | 0 |
| 2022-06-24 | XFOR | Sale | 856 | .00 | 0 |
| 2022-06-16 | XFOR | Sale | 856 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Dibiase Mary (Chief Operating Officer of X4 Pharmaceuticals, Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.